Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|August 15, 2006
Hdmx modulates the outcome of p53 activation in human tumor cellsMark Wade, Ee Tsin Wong, Mengjia Tang, et al.
NPJ Breast Cancer|June 27, 2017
Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesisChristy L Trejo, Gidsela Luna, Christopher Dravis, et al.
Anti-Cancer Drugs|March 27, 2002
Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011Christopher R Boyer, Patricia L Karjian, Geoffrey M Wahl, et al.
Journal of Mammary Gland Biology and Neoplasia|April 30, 2013
Stem cells and the developing mammary glandMaisam Makarem, Benjamin T Spike, Christopher Dravis, et al.
Life Science Alliance|January 22, 2020
Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodelingSimone Bersini, Nikki K Lytle, Roberta Schulte, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2007
Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activationYunyuan V Wang, Mark Wade, Eetsin Wong, et al.
Molecular and Cellular Biology|December 13, 2006
Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppressionFranck Toledo, Crystal J Lee, Kurt A Krummel, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironmentJeffrey Reina, Queralt Vallmajo-Martin, Jia Ning, et al.
Cell Stem Cell|February 7, 2012
A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancerBenjamin T Spike, Dannielle D Engle, Jennifer C Lin, et al.
Pageof 8